Patterson JH - Search Results

1

Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers.

Fischer TL, Pieper JA, Graff DW, Rodgers JE, Fischer JD, Parnell KJ, Goldstein JA, Greenwood R, Patterson JH. Fischer TL, et al. Among authors: patterson jh. Clin Pharmacol Ther. 2002 Sep;72(3):238-46. doi: 10.1067/mcp.2002.127945. Clin Pharmacol Ther. 2002. PMID: 12235444 Clinical Trial.

2

The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure.

Carlton LD, Patterson JH, Mattson CN, Schmith VD. Carlton LD, et al. Among authors: patterson jh. J Clin Pharmacol. 1996 Mar;36(3):247-56. doi: 10.1002/j.1552-4604.1996.tb04195.x. J Clin Pharmacol. 1996. PMID: 8690819 Clinical Trial.

3

The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failure.

Carlton LD, Patterson JH, Mattson CN, Schmith VD. Carlton LD, et al. Among authors: patterson jh. J Clin Pharmacol. 1996 Mar;36(3):257-64. doi: 10.1002/j.1552-4604.1996.tb04196.x. J Clin Pharmacol. 1996. PMID: 8690820 Clinical Trial.

4

Effects of ofloxacin on the pharmacokinetics and pharmacodynamics of procainamide.

Martin DE, Shen J, Griener J, Raasch R, Patterson JH, Cascio W. Martin DE, et al. Among authors: patterson jh. J Clin Pharmacol. 1996 Jan;36(1):85-91. doi: 10.1002/j.1552-4604.1996.tb04156.x. J Clin Pharmacol. 1996. PMID: 8932548 Clinical Trial.

5

Pharmacogenetics and heart failure: a convergence with carvedilol.

Meadowcroft AM, Williamson KM, Patterson JH, Pieper JA. Meadowcroft AM, et al. Among authors: patterson jh. Pharmacotherapy. 1997 Jul-Aug;17(4):637-9. Pharmacotherapy. 1997. PMID: 9250542 No abstract available.

6

Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers.

Williamson KM, Patterson JH, McQueen RH, Adams KF Jr, Pieper JA. Williamson KM, et al. Among authors: patterson jh. Clin Pharmacol Ther. 1998 Mar;63(3):316-23. doi: 10.1016/S0009-9236(98)90163-1. Clin Pharmacol Ther. 1998. PMID: 9542475

7

The effects of fluvastatin, a CYP2C9 inhibitor, on losartan pharmacokinetics in healthy volunteers.

Meadowcroft AM, Williamson KM, Patterson JH, Hinderliter AL, Pieper JA. Meadowcroft AM, et al. Among authors: patterson jh. J Clin Pharmacol. 1999 Apr;39(4):418-24. doi: 10.1177/00912709922007886. J Clin Pharmacol. 1999. PMID: 10197301 Clinical Trial.

8

The role of the renin-angiotensin-aldosterone system in the management of heart failure.

Rodgers JE, Patterson JH. Rodgers JE, et al. Among authors: patterson jh. Pharmacotherapy. 2000 Nov;20(11 Pt 2):368S-378S. doi: 10.1592/phco.20.18.368s.34606. Pharmacotherapy. 2000. PMID: 11089708 Review.

9

Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients.

Graff DW, Williamson KM, Pieper JA, Carson SW, Adams KF Jr, Cascio WE, Patterson JH. Graff DW, et al. Among authors: patterson jh. J Clin Pharmacol. 2001 Jan;41(1):97-106. doi: 10.1177/00912700122009746. J Clin Pharmacol. 2001. PMID: 11225566 Clinical Trial.

10

Angiotensin II-receptor blockers: clinical relevance and therapeutic role.

Rodgers JE, Patterson JH. Rodgers JE, et al. Among authors: patterson jh. Am J Health Syst Pharm. 2001 Apr 15;58(8):671-83. doi: 10.1093/ajhp/58.8.671. Am J Health Syst Pharm. 2001. PMID: 11329759 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters